| Carrie Jane Smigelski, MED, CCC-SLP | |
|
8514 W Gage Blvd, Kennewick, WA 99336-8120 | |
| (509) 735-6442 | |
| Not Available |
| Full Name | Carrie Jane Smigelski |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 8514 W Gage Blvd, Kennewick, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144464181 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SI60024943 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carrie Jane Smigelski, MED, CCC-SLP 8514 W Gage Blvd, Kennewick, WA 99336-8120 Ph: (509) 735-6442 | Carrie Jane Smigelski, MED, CCC-SLP 8514 W Gage Blvd, Kennewick, WA 99336-8120 Ph: (509) 735-6442 |
News Archive
It started with a 44-year-old woman with solitary fibrous tumor, a rare cancer seen in only a few hundred people each year. By looking at the entire DNA from this one patient's tumor, researchers have found a genetic anomaly that provides an important clue to improving how this cancer is diagnosed and treated.
People who suffer with persistent asthma from a young age are more likely to leave school at 16 years old and those who make it to university are more likely to drop out early, according to new research presented today (Sunday) at the European Respiratory Society International Congress.
Researchers at the University of Texas at Arlington's College of Nursing and Health Innovation have developed a new nanoparticle-based platform for simultaneous imaging and treatment of esophageal cancer.
X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 antagonists to improve immune cell trafficking to treat cancer and rare disease, today announced results from a pilot study of X4P-001-IO in combination with Opdivo (nivolumab) in patients with clear cell renal cell carcinoma who are non-responsive to the anti-PD-1 checkpoint inhibitor Opdivo alone.
› Verified 7 days ago
Courtney Christensen, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 S Conway Pl, Kennewick, WA 99336 Phone: 509-222-6992 | |
Erika Hartoonian, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 W 4th Ave, Kennewick, WA 99336 Phone: 509-222-6570 | |
Dana Wood, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 S Conway Pl, Kennewick, WA 99336 Phone: 509-222-5028 | |
Mrs. Lael Marie Mether, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 909 S Buntin St, Kennewick, WA 99336 Phone: 509-987-4564 | |
Mrs. Christine Boynton Tano, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10411 E Vaca Rd, Kennewick, WA 99338 Phone: 509-628-3744 | |
Hector Gustavo Arriaga, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1022 W Bruneau Ave, Kennewick, WA 99336 Phone: 509-579-2327 | |
Mrs. Pamela Dee Ragle, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 552 N Colorado St Ste 210, Kennewick, WA 99336 Phone: 509-734-2575 Fax: 186-654-6859 |